Halozyme Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2013-03-31 | $29M | 5.0M | 5.77 |
2012-12-31 | $35M | 5.2M | 6.71 |
2012-09-30 | $38M | 5.0M | 7.56 |
2012-03-31 | $60M | 4.7M | 12.76 |
2011-09-30 | $26M | 4.2M | 6.14 |
2011-06-30 | $28M | 4.1M | 6.91 |
2011-03-31 | $27M | 4.0M | 6.71 |